Director/PDMR Shareholding
RNS & Investor News
Holding(s) in Company
07 October 2015
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | OptiBiotix Health Plc | ||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||||
| An acquisition or disposal of voting rights | X | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
| An event changing the breakdown of voting rights | |||||
| Other (please specify): | |||||
| 3. Full name of person(s) subject to the notification obligation: iii | Finance Yorkshire Seedcorn Fund (FYSCF) | ||||
| 4. Full name of shareholder(s) (if different from 3.):iv | |||||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v | 25 September 2015 | ||||
| 6. Date on which issuer notified: | 7 October 2015 | ||||
| 7. Threshold(s) that is/are crossed or reached: vi, vii | 18% | ||||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | ||||||||||||
| Direct | Direct xi | Indirectxii | Direct | Indirect | ||||||||||||
| GB00BP0RTP38 | 13,998,238 | 13,998,238 | 12,598,238 | 12,598,238 | nil | 17.120 | Nil | |||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Expiration date xiii | Exercise/Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||
| None | ||||||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|||||||||||
| None | Nominal | Delta | ||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| 12,598,238 | 17.12% | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | ||
| 11. Number of voting rights proxy holder will cease to hold: | ||
| 12. Date on which proxy holder will cease to hold voting rights: | ||
| 13. Additional information: | ||
| 14. Contact name: | Enterprise Ventures Limited | |
| 15. Contact telephone number: | 01772 270 570 | |
Latest RNS News
Latest Video
OptiBiotix Health PLC - Full Year Results Investor
Presentation
Group CEO Stephen O'Hara | July 2025
Latest Podcast
Stephen OHara interview with Investors
Champion
Stephen O'Hara | 04 Jul 2019
www.investorschampion.com